MS is most frequently observed in people living with HIV, including those with normal CD4+ T-cell counts under antiretroviral therapy, as well as individuals with uncontrolled HIV infection not receiving ART [7,31,32]. This evidence concerns the gene CD4 and myeloid sarcoma.